cheaptrix/billsum-US_congress_and_house huggingface dataset:
A bill to ensure that no cost reduction or cash refund is due under certain transportation cost-reimbursement contracts on the basis of the forgiveness of certain covered loans, and for other purposes.

To ensure that no cost reduction or cash refund is due under certain transportation cost-reimbursement contracts on the basis of the forgiveness of certain covered loans, and for other purposes. 1. Treatment of paycheck protection program loan forgiveness of payroll costs under highway and public transportation project cost-reimbursement contracts (a) In general Notwithstanding section 31.201–5 of title 48, Code of Federal Regulations (or successor regulations), for the purposes of any cost-reimbursement contract awarded in accordance with section 112 of title 23, United States Code, or section 5325 of title 49, United States Code, or any subcontract under such a contract, no cost reduction or cash refund (including through a reduced indirect cost rate) shall be due to the Department of Transportation or to a State transportation department, transit agency, or other recipient of assistance under chapter 1 chapter 53 15 U.S.C. 636m(a) 15 U.S.C. 636(a)(36) (b) Saving provision Nothing in this section amends or exempts the prohibitions and liabilities under section 3729 of title 31, United States Code. (c) Termination This section ceases to be effective on June 30, 2025.

Summary: This bill exempts until June 30, 2025, certain contractors that receive federal highway or public transportation funding from having to adjust costs associated with their contracts to account for loan forgiveness through the Paycheck Protection Program (PPP). (The PPP provided small businesses with loans for payroll and other costs to respond to the COVID-19 emergency with loan forgiveness under certain conditions.) Under current law, a contractor with a cost-reimbursable contract must reduce costs or provide cash refunds to the Department of Transportation (or a state department of transportation) if the contractor receives or accrues any income, rebate, allowance, or other credit relating to an allowable contract cost, which includes PPP loan forgiveness.
Reproductive Choice Act

To codify the essential holdings of Roe v. Wade (410 U.S. 113 (1973)) and Planned Parenthood of Southeastern Pennsylvania v. Casey (505 U.S. 833 (1992)). 1. Short title This Act may be cited as the Reproductive Choice Act 2. Purpose It is the purpose of this Act to codify the essential holdings of Roe v. Wade (410 U.S. 113 (1973)) and Planned Parenthood of Southeastern Pennsylvania v. Casey (505 U.S. 833 (1992)). 3. Clarification of allowable State requirements (a) In general A State— (1) may not impose an undue burden on the ability of a woman to choose whether or not to terminate a pregnancy before fetal viability; (2) may restrict the ability of a woman to choose whether or not to terminate a pregnancy after fetal viability, unless such a termination is necessary to preserve the life or health of the woman; and (3) may enact regulations to further the health or safety of a woman seeking to terminate a pregnancy. (b) Clarification For purposes of this Act, unnecessary health regulations that have the purpose or effect of presenting a substantial obstacle to a woman seeking to terminate a pregnancy impose an undue burden. (c) Rule of construction Nothing in this Act shall be construed to have any effect on laws regarding conscience protection. 4. Definitions In this Act: (1) State The term State (2) Undue burden The term undue burden

Summary: Reproductive Choice Act This bill provides statutory authority for certain Supreme Court holdings on abortion rights and restrictions in the cases of Roe v. Wade and Planned Parenthood of Southeastern Pennsylvania v. Casey. In Roe, the Court held that the Constitution protects a woman's decision to terminate her pregnancy. In Casey, the Court reaffirmed this holding and additionally held that state abortion regulations may not place a substantial obstacle in the path of a woman seeking an abortion before fetal viability (i.e., an undue burden). However, a state may (1) restrict abortions after viability, except when a pregnancy endangers the life or health of the woman; and (2) enact regulations to further the health or safety of a woman seeking an abortion, except for unnecessary health regulations that present a substantial obstacle to a woman seeking an abortion. The bill provides statutory authority for these holdings. It also specifies that the bill does not affect laws regarding conscience protection.
Tracking Bad Actors Act of 2022

To require Federal financial regulators to create a publicly available database for certain bad actors, and for other purposes. 1. Short title This Act may be cited as the Tracking Bad Actors Act of 2022 2. Definition In this Act, the term Federal financial regulator (1) the Commodity Futures Trading Commission; (2) the Securities and Exchange Commission; (3) the Office of the Comptroller of the Currency; (4) the Federal Deposit Insurance Corporation; (5) the Financial Industry Regulatory Agency; and (6) the Public Company Accounting Oversight Board. 3. Database (a) In general Not later than 3 years after the date of enactment of this Act, the Federal financial regulators shall jointly establish a publicly available database of persons convicted or held liable in criminal, civil, and administrative actions relating to financial services brought by— (1) any Federal financial regulator, to the greatest extent practicable; (2) the Department of Justice; (3) any self-regulatory organization or similar entity overseen by a Federal financial regulator if required by such regulator; or (4) any State or local criminal or regulatory agency that voluntarily submits information to the database. (b) Oversight The Securities and Exchange Commission shall be the lead agency responsible for oversight of the database established under subsection (a). (c) Free access The information in the database established under subsection (a) shall be free of charge to the public. (d) Operation The database established under subsection (a) shall be operated by a Federal agency or maintained by a third party. (e) Expungement Any agency who submits information to the database under subsection (a) shall expunge any enforcement action brought by the agency if the action is— (1) overturned upon judicial review; or (2) withdrawn by the agency. (f) Reports (1) Federal financial regulators The Federal financial regulators shall jointly submit to Congress an annual report on the database during the period beginning on the date of enactment of this Act and ending on the date on which the database is operational. (2) GAO report Not later than 5 years after the date on which the database is operational, the Comptroller General of the United States shall submit to Congress a report on the database.

Summary: Tracking Bad Actors Act of 2022 This bill requires federal financial regulators to jointly publish a database of persons convicted or held liable in criminal, civil, or administrative actions regarding financial services that are brought by federal financial regulators, the Department of Justice, certain self-regulating organizations, or state or local agencies that voluntarily submit such information. The Government Accountability Office must report on the database five years after the database is operational.
A bill to withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the Russian Federation, and for other purposes.

To withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the Russian Federation, and for other purposes. 1. Short title This Act may be known as the No Most Favored Nation Trading with Russia Act 2. Withdrawal of normal trade relations treatment with the Russian Federation Notwithstanding the provisions of title I of the Russia and Moldova Jackson-Vanik Repeal and Sergei Magnitsky Rule of Law Accountability Act of 2012 ( Public Law 112–208 19 U.S.C. 2434 (1) normal trade relations treatment shall not apply pursuant to section 102 of that Act to the products of the Russian Federation; and (2) normal trade relations treatment may thereafter be extended to the products of the Russian Federation only in accordance with the provisions of chapter 1 of title IV of the Trade Act of 1974 ( 19 U.S.C. 2431 et seq. 3. Cooperation with United States allies and partners (a) In general The President shall encourage allies and partners of the United States— (1) to consider taking actions similar to the actions taken under section 2, such as the withdrawal of permanent normal trade relations treatment for products of the Russian Federation; and (2) to condemn at the World Trade Organization the recent aggression by the Government of the Russian Federation in Ukraine. (b) Accountability at the WTO The President shall direct the Permanent Mission of the United States to the World Trade Organization to use the voice, vote, and influence of the United States at the World Trade Organization to seek the suspension of the membership of the Russian Federation in the World Trade Organization. March 2, 2022 Read the second time and placed on the calendar

Summary: No Most Favored Nation Trading with Russia Act This bill withdraws normal trade relations treatment from Russia. Additionally, the bill requires the President to encourage U.S. allies and partners to (1) consider taking similar actions; and (2) condemn, at the World Trade Organization (WTO), Russia's aggression in Ukraine. Further, the President must direct the U.S. Permanent Representative to the WTO to seek suspension of Russia's membership in the WTO.
A bill to prohibit the importation of petroleum and petroleum products from the Russian Federation.

To prohibit the importation of petroleum and petroleum products from the Russian Federation. 1. Prohibition on importation of petroleum and petroleum products from the Russian Federation (a) Finding Congress makes the following findings: (1) Article XXI of the General Agreement on Tariffs and Trade provides for security exceptions to the rules of the World Trade Organization to allow a member of the World Trade Organization to take actions necessary for the protection of its essential security interests time of war or other emergency in international relations to prevent any contracting party from taking any action in pursuance of its obligations under the United Nations Charter for the maintenance of international peace and security (2) The aggression of the Russian Federation against Ukraine warrants taking action permitted under that Article. (b) Prohibition The importation of petroleum and petroleum products from the Russian Federation is prohibited. (c) Effective date (1) In general Subject to paragraph (2), the prohibition under subsection (b) applies with respect to petroleum and petroleum products entered, or withdrawn from warehouse for consumption, after the date that is 15 days after the date of the enactment of this Act. (2) Transition rule The prohibition under subsection (b) does not apply with respect to petroleum and petroleum products in transit to the United States on the day before the date of the enactment of this Act.

Summary: This bill prohibits the importation of petroleum and petroleum products from Russia.
Ensuring Quality Care for Our Veterans Act

To require the Secretary of Veterans Affairs to enter into a contract or other agreement with a third party to review appointees in the Veterans Health Administration who had a license terminated for cause by a State licensing board for care or services rendered at a non-Veterans Health Administration facility and to provide individuals treated by such an appointee with notice if it is determined that an episode of care or services that they received was below the standard of care, and for other purposes. 1. Short title This Act may be cited as the Ensuring Quality Care for Our Veterans Act 2. Third party review of appointees in Veterans Health Administration who had a license terminated for cause and notice to individuals treated by those appointees if determined that an episode of care or services that they received was below the standard of care (a) Third party review (1) In general Not later than 180 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall enter into a contract or other agreement with an organization that is not part of the Federal Government to conduct a clinical review for quality management of hospital care or medical services furnished by covered providers. (2) Qualifications The Secretary shall ensure that each review of a covered provider under this subsection is performed by an individual who is licensed in the same specialty as the covered provider. (b) Notice to patients treated by covered providers With respect to hospital care or medical services furnished by a covered provider under the laws administered by the Secretary, if a clinical review for quality management under subsection (a) determines that the standard of care was not met during an episode of care, the Secretary shall notify the individual who received such care or services from the covered provider as described in applicable policy of the Veterans Heath Administration. (c) Definitions In this section: (1) Covered provider The term covered provider (A) was appointed to the Veterans Health Administration under section 7401 of title 38, United States Code; and (B) had a license terminated for cause by a State licensing board for hospital care or medical services provided in a facility that is not a facility of the Veterans Health Administration. (2) Hospital care or medical services The terms hospital care medical services

Summary: Ensuring Quality Care for Our Veterans Act This bill directs the Department of Veterans Affairs (VA) to contract with a nonfederal organization to conduct a quality management review of hospital care or medical services furnished by each Veterans Health Administration (VHA) provider whose license was terminated by a state licensing board based upon care or services provided in a non-VHA facility. If a review determines that the standard of care was not met, the VA shall notify the individual who received such care or services.
A bill to withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the Russian Federation, and for other purposes.

To withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the Russian Federation, and for other purposes. 1. Short title This Act may be known as the No Most Favored Nation Trading with Russia Act 2. Withdrawal of normal trade relations treatment with the Russian Federation Notwithstanding the provisions of title I of the Russia and Moldova Jackson-Vanik Repeal and Sergei Magnitsky Rule of Law Accountability Act of 2012 ( Public Law 112–208 19 U.S.C. 2434 (1) normal trade relations treatment shall not apply pursuant to section 102 of that Act to the products of the Russian Federation; and (2) normal trade relations treatment may thereafter be extended to the products of the Russian Federation only in accordance with the provisions of chapter 1 of title IV of the Trade Act of 1974 ( 19 U.S.C. 2431 et seq. 3. Proclamation of tariffs With regard to products of the Russian Federation, the President may proclaim modifications to the rates set forth in the column 2 rate of duty column of the Harmonized Tariff Schedule of the United States if the President determines that the modifications are necessary for the protection of the essential security of the United States. 4. Cooperation with United States allies and partners (a) In general The President shall encourage allies and partners of the United States— (1) to consider taking actions similar to the actions taken under section 2, such as the withdrawal of permanent normal trade relations treatment for products of the Russian Federation; and (2) to condemn at the World Trade Organization the recent aggression by the Government of the Russian Federation in Ukraine. (b) Accountability at the WTO The President shall direct the Permanent Mission of the United States to the World Trade Organization to use the voice and influence of the United States at the World Trade Organization to seek the suspension of the membership of the Russian Federation in the World Trade Organization.

Summary: No Most Favored Nation Trading with Russia Act This bill withdraws normal trade relations treatment from Russia. Additionally, the bill requires the President to encourage U.S. allies and partners to (1) consider taking similar actions; and (2) condemn, at the World Trade Organization (WTO), Russia's aggression in Ukraine. Further, the President must direct the U.S. Permanent Representative to the WTO to seek suspension of Russia's membership in the WTO. The President may proclaim modifications to the applicable duty rates on products from Russia (under column 2 of the Harmonized Tariff Schedule) if the President determines that the modifications are necessary to protect the essential security of the United States.
RETURN Act

To ensure that employees of the Internal Revenue Service are brought back to their offices until the backlog of 2020 tax returns has been eliminated. 1. Short title This Act may be cited as the Require Employees To Uniformly Return Now Act RETURN Act 2. Bringing IRS employees back to the office (a) In general Notwithstanding any other law, in the case of an applicable employee, such employee shall not be authorized to telework during the period— (1) beginning on the date that is 5 business days after the date of enactment of this Act, and (2) ending on the date on which the Commissioner of Internal Revenue certifies that the processing backlog with respect to income tax returns for taxable year 2020 has been eliminated. (b) Definitions In this section— (1) Applicable employee The term applicable employee (2) Telework The term telework

Summary: Require Employees To Uniformly Return Now Act or the RETURN Act This bill prohibits Internal Revenue Service (IRS) employees from teleworking during the period beginning five business days after the enactment of this bill and ending on the date on which the IRS certifies that the processing backlog for 2020 income tax returns has been eliminated.
Colorado National Heritage Areas Reauthorization Act

To amend the Omnibus Public Land Management Act of 2009 to reauthorize the Sangre de Cristo National Heritage Area, Cache La Poudre National Heritage Area, and South Park National Heritage Area in the State of Colorado, and for other purposes. 1. Short title This Act may be cited as the Colorado National Heritage Areas Reauthorization Act 2. Reauthorization of certain National Heritage Areas in the State of Colorado (a) Sangre de Cristo National Heritage Area Section 8001(i) of the Omnibus Public Land Management Act of 2009 ( 54 U.S.C. 320101 Public Law 111–11 the date that is 15 years after the date of enactment of this Act September 30, 2036 (b) Cache La Poudre National Heritage Area Section 8002(i) of the Omnibus Public Land Management Act of 2009 ( 54 U.S.C. 320101 Public Law 111–11 the date that is 15 years after the date of enactment of this Act September 30, 2036 (c) South Park National Heritage Area Section 8003(i) of the Omnibus Public Land Management Act of 2009 ( 54 U.S.C. 320101 Public Law 111–11 the date that is 15 years after the date of enactment of this Act September 30, 2036

Summary: Colorado National Heritage Areas Reauthorization Act This bill extends through FY2036 the authority of the Department of the Interior to provide assistance for the Sangre de Cristo National Heritage Area, the Cache la Poudre River National Heritage Area, and the South Park National Heritage Area.
Advocacy Empowerment Act of 2022

To amend section 203 of Public Law 94–305 1. Short title This Act may be cited as the Advocacy Empowerment Act of 2022 2. Additional powers of the Chief Counsel for Advocacy (a) Chief counsel authority Section 203(a) of Public Law 94–305 15 U.S.C. 634c(a) (1) in paragraph (5), by striking and (2) in paragraph (6), by striking the period at the end and inserting a semicolon; and (3) by adding at the end the following: (7) issue, modify, or amend rules governing compliance by agencies with chapter 6 (8) authorize an agency to issue such supplemental rules governing compliance with chapter 6 . (b) Implementation On and after the date that is 270 days after the date of enactment of this Act, the Chief Counsel for Advocacy of the Small Business Administration may exercise the authority under paragraphs (7) and (8) of section 203(a) of Public Law 94–305 15 U.S.C. 634c(a)

Summary: Advocacy Empowerment Act of 2022 This bill revises the duties of the Chief Counsel for Advocacy of the Small Business Administration to include (1) issuing, modifying, or amending rules governing federal agency compliance with regulatory flexibility analysis requirements; and (2) authorizing an agency to issue such supplemental rules governing such compliance as the Chief Counsel may approve.
BENEFIT Act of 2021

To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs. 1. Short title This Act may be cited as the Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 BENEFIT Act of 2021 2. Strengthening the use of patient-experience data within benefit-risk framework Section 569C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–8c (1) in subsection (a)(1)— (A) in subparagraph (A), by striking ; and (B) in subparagraph (B), by striking the period and inserting ; and (C) by adding at the end the following: (C) as part of the risk-benefit assessment framework in the new drug approval process described in section 505(d), considering relevant patient-focused drug development data, such as data from patient preference studies (benefit-risk), patient reported outcome data, or patient experience data, developed by the sponsor of an application or another party. ; and (2) in subsection (b)(1), by inserting , including a description of how such data and information were considered in the risk benefit assessment described in section 505(d)

Summary: Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021 This bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs. After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.